Iradimed Corp - Understand $irmd stock

$IRMD Market Cap: $693.5 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$71.31M

TTM

Gross Margin

77.13%

TTM

Net Earnings

$18.63M

TTM

Current Assets

$74.29M

Q3 2024

Current Liabilities

$8.063M

Q3 2024

Current Ratio

921.32%

Q3 2024

Total Assets

$94.25M

Q3 2024

Total Liabilities

$10.81M

Q3 2024

Book Value

$83.43M

Q3 2024

Cash

$51.72M

Q3 2024

P/E

37.23

Nov 29, 2024 EST

Free Cash Flow

$17.37M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$65.56M	$53.30M	$41.81M	$31.72M	$38.52M	$30.44M	$23.08M	$32.50M	$31.59M	$15.65M	$11.34M	$7.690M
YoY Change	23.0%	27.48%	31.83%	-17.65%	26.54%	31.88%	-28.98%	2.88%	101.85%	38.01%	47.46%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$65.56M	$53.30M	$41.81M	$31.72M	$38.52M	$30.44M	$23.08M	$32.50M	$31.59M	$15.65M	$11.34M	$7.690M
Cost Of Revenue	$15.40M	$12.02M	$9.765M	$8.143M	$8.816M	$7.212M	$5.570M	$6.150M	$5.840M	$3.400M	$2.850M	$2.130M
Gross Profit	$50.16M	$41.28M	$32.05M	$23.57M	$29.70M	$23.23M	$17.51M	$26.34M	$25.75M	$12.25M	$8.490M	$5.560M
Gross Profit Margin	76.5%	77.45%	76.65%	74.33%	77.11%	76.31%	75.87%	81.05%	81.51%	78.27%	74.87%	72.3%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Selling, General & Admin	$27.26M	$23.38M	$20.33M	$22.43M	$19.62M	$15.71M	$14.50M	$14.07M	$12.48M	$8.110M	$4.690M	$3.480M
YoY Change	16.63%	15.0%	-9.37%	14.31%	24.92%	8.32%	3.06%	12.74%	53.88%	72.92%	34.77%
% of Gross Profit	54.36%	56.63%	63.42%	95.14%	66.06%	67.62%	82.81%	53.42%	48.47%	66.2%	55.24%	62.59%
Research & Development	$2.859M	$2.278M	$1.905M	$1.903M	$1.433M	$1.517M	$1.720M	$1.350M	$1.760M	$1.070M	$1.010M	$650.0K
YoY Change	25.49%	19.58%	0.13%	32.79%	-5.56%	-11.8%	27.41%	-23.3%	64.49%	5.94%	55.38%
% of Gross Profit	5.7%	5.52%	5.94%	8.07%	4.82%	6.53%	9.82%	5.13%	6.83%	8.73%	11.9%	11.69%
Depreciation & Amortization	$765.2K	$670.7K	$1.407M	$1.339M	$1.242M	$1.105M	$1.310M	$960.0K	$810.0K	$150.0K	$140.0K	$110.0K
YoY Change	14.09%	-52.33%	5.08%	7.77%	12.43%	-15.65%	36.46%	18.52%	440.0%	7.14%	27.27%
% of Gross Profit	1.53%	1.62%	4.39%	5.68%	4.18%	4.76%	7.48%	3.64%	3.15%	1.22%	1.65%	1.98%
Operating Expenses	$30.12M	$25.65M	$22.23M	$24.33M	$21.05M	$17.22M	$16.23M	$15.43M	$14.24M	$9.190M	$5.700M	$4.130M
YoY Change	17.42%	15.39%	-8.62%	15.56%	22.24%	6.12%	5.18%	8.36%	54.95%	61.23%	38.01%
Operating Profit	$20.04M	$15.63M	$9.818M	-$756.1K	$8.647M	$6.004M	$1.280M	$10.91M	$11.51M	$3.060M	$2.790M	$1.430M
YoY Change	28.21%	59.18%	-1398.48%	-108.74%	44.03%	369.04%	-88.27%	-5.21%	276.14%	9.68%	95.1%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Expense	$1.715M	$553.1K	$18.61K	$140.0K	$400.0K	$190.0K	$110.0K	-$10.00K	-$20.00K	-$60.00K	-$20.00K	-$10.00K
YoY Change	210.12%	2872.06%	-86.71%	-65.0%	110.53%	72.73%	-1200.0%	-50.0%	-66.67%	200.0%	100.0%
% of Operating Profit	8.56%	3.54%	0.19%		4.63%	3.16%	8.59%	-0.09%	-0.17%	-1.96%	-0.72%	-0.7%
Other Income/Expense, Net	$1.703M	$553.1K	$18.61K	$139.2K	$395.9K	$193.5K		$40.00K	$150.0K	$10.00K	$20.00K	$20.00K
YoY Change	207.86%	2872.86%	-86.64%	-64.84%	104.57%			-73.33%	1400.0%	-50.0%	0.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Pretax Income	$21.74M	$16.18M	$9.836M	-$616.9K	$9.043M	$6.197M	$1.400M	$10.95M	$11.63M	$3.020M	$2.780M	$1.430M
YoY Change	34.35%	64.5%	-1694.53%	-106.82%	45.92%	342.66%	-87.21%	-5.85%	285.1%	8.63%	94.41%
Income Tax	$4.545M	$3.353M	$510.8K	-$1.986M	-$587.6K	-$106.1K	$420.0K	$3.740M	$4.100M	$970.0K	$850.0K	$470.0K
% Of Pretax Income	20.91%	20.72%	5.19%		-6.5%	-1.71%	30.0%	34.16%	35.25%	32.12%	30.58%	32.87%
Net Earnings	$17.19M	$12.83M	$9.325M	$1.369M	$9.631M	$6.303M	$500.0K	$7.210M	$7.530M	$2.050M	$1.940M	$970.0K
YoY Change	34.03%	37.55%	581.19%	-85.79%	52.79%	1160.69%	-93.07%	-4.25%	267.32%	5.67%	100.0%
Net Earnings / Revenue	26.22%	24.06%	22.3%	4.32%	25.0%	20.71%	2.17%	22.18%	23.84%	13.1%	17.11%	12.61%
Basic Earnings Per Share	$1.36	$1.02	$0.76	$0.11	$0.85	$0.59
Diluted Earnings Per Share	$1.35	$1.015M	$0.74	$0.11	$0.78	$0.52	$42.66K	$601.3K	$599.5K	$200.6K	$191.1K	$95.57K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash & Short-Term Investments	$49.76M	$57.96M	$62.50M	$51.98M	$46.25M	$34.38M	$26.34M	$25.68M	$26.97M	$17.37M	$2.710M	$1.950M
YoY Change	-14.15%	-7.26%	20.24%	12.39%	34.53%	30.52%	2.57%	-4.78%	55.27%	540.96%	38.97%
Cash & Equivalents	$49.76M	$57.96M	$62.00M	$50.07M	$43.48M	$28.03M	$18.21M	$17.71M	$19.37M	$9.450M	$2.460M	$1.700M
Short-Term Investments		$0.00	$501.9K	$1.910M	$2.770M	$6.350M	$8.140M	$7.970M	$7.600M	$7.910M	$250.0K	$250.0K
Other Short-Term Assets	$1.193M	$20.23M	$1.001M	$770.0K	$410.0K	$530.0K	$650.0K	$360.0K	$460.0K	$400.0K	$190.0K	$80.00K
YoY Change	-94.1%	1921.4%	29.96%	87.8%	-22.64%	-18.46%	80.56%	-21.74%	15.0%	110.53%	137.5%
Inventory	$12.82M	$5.369M	$4.300M	$3.930M	$3.640M	$4.060M	$4.210M	$3.890M	$2.380M	$2.130M	$1.340M	$1.390M
Prepaid Expenses
Receivables	$12.22M	$13.27M	$5.137M	$4.570M	$7.290M	$4.210M	$3.780M	$3.780M	$3.860M	$1.960M	$1.980M	$1.590M
Other Receivables	$0.00	$254.1K	$3.306M	$2.480M	$1.370M	$1.370M	$130.0K	$150.0K	$280.0K	$320.0K	$170.0K	$0.00
Total Short-Term Assets	$76.00M	$78.19M	$76.24M	$63.74M	$58.96M	$44.54M	$35.11M	$33.86M	$33.95M	$22.17M	$6.390M	$5.000M
YoY Change	-2.8%	2.55%	19.62%	8.11%	32.38%	26.86%	3.69%	-0.27%	53.13%	246.95%	27.8%
Property, Plant & Equipment	$11.33M	$2.400M	$4.551M	$4.840M	$5.010M	$1.870M	$1.870M	$1.460M	$910.0K	$790.0K	$330.0K	$270.0K
YoY Change	372.19%	-47.27%	-5.96%	-3.39%	167.91%	0.0%	28.08%	60.44%	15.19%	139.39%	22.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.304M	$4.923M	$966.4K	$1.530M	$1.900M	$1.200M	$1.150M	$960.0K	$190.0K	$100.0K	$10.00K	$20.00K
YoY Change	-53.2%	409.45%	-36.84%	-19.47%	58.33%	4.35%	19.79%	405.26%	90.0%	900.0%	-50.0%
Total Long-Term Assets	$16.15M	$7.323M	$6.636M	$7.330M	$7.770M	$3.900M	$3.900M	$3.330M	$1.290M	$1.140M	$600.0K	$550.0K
YoY Change	120.6%	10.35%	-9.46%	-5.66%	99.23%	0.0%	17.12%	158.14%	13.16%	90.0%	9.09%
Total Assets	$92.16M	$85.51M	$82.88M	$71.07M	$66.73M	$48.44M	$39.01M	$37.19M	$35.24M	$23.31M	$6.990M	$5.550M
YoY Change
Accounts Payable	$1.857M	$1.799M	$782.9K	$660.0K	$990.0K	$770.0K	$660.0K	$1.120M	$1.010M	$630.0K	$430.0K	$410.0K
YoY Change	3.21%	129.83%	18.62%	-33.33%	28.57%	16.67%	-41.07%	10.89%	60.32%	46.51%	4.88%
Accrued Expenses	$3.306M	$3.287M	$3.231M	$2.070M	$3.000M	$1.940M	$1.620M	$1.150M	$1.320M	$1.310M	$740.0K	$560.0K
YoY Change	0.58%	1.73%	56.11%	-31.0%	54.64%	19.75%	40.87%	-12.88%	0.76%	77.03%	32.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$520.0K
YoY Change										-100.0%	-98.08%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$16.33M	$8.554M	$6.823M	$4.920M	$5.860M	$4.690M	$4.080M	$3.660M	$2.890M	$2.280M	$1.450M	$2.330M
YoY Change	90.88%	25.37%	38.67%	-16.04%	24.95%	14.95%	11.48%	26.64%	26.75%	57.24%	-37.77%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.409M	$3.287M	$3.885M	$4.760M	$5.350M	$1.810M	$2.000M	$1.640M	$420.0K	$140.0K	$60.00K	$0.00
YoY Change	34.12%	-15.39%	-18.39%	-11.03%	195.58%	-9.5%	21.95%	290.48%	200.0%	133.33%
Total Long-Term Liabilities	$4.409M	$3.287M	$3.885M	$4.760M	$5.350M	$1.810M	$2.000M	$1.640M	$420.0K	$140.0K	$60.00K	$0.00
YoY Change	34.12%	-15.39%	-18.39%	-11.03%	195.58%	-9.5%	21.95%	290.48%	200.0%	133.33%
Total Liabilities	$20.74M	$11.84M	$10.71M	$9.680M	$11.20M	$6.500M	$6.080M	$5.310M	$3.310M	$2.420M	$1.560M	$2.330M
YoY Change	75.12%	10.58%	10.62%	-13.57%	72.31%	6.91%	14.5%	60.42%	36.78%	55.13%	-33.05%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Basic Shares Outstanding	12.60M	12.56M	12.35M	12.12M	11.28M	10.76M	10.64M	10.82M	11.00M	8.743M
Diluted Shares Outstanding	12.72M	12.64M	12.59M	12.44M	12.28M	12.11M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $693.49 Million

About IRADIMED CORP

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 148 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES ZYNEX INC Axogen, Inc. Cue Health Inc. Vicarious Surgical Inc. Orthofix Medical Inc. Sight Sciences, Inc. Semler Scientific, Inc. SURMODICS INC ZimVie Inc.